Thomas Weisel Upgrades Medicis Pharmaceutical (MRX); Bernstein Downgrades MRX
MRX Hot Sheet
Rating Summary:10 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 18 | New: 27
Thomas Weisel upgrades Medicis Pharmaceutical (NYSE: MRX) from Marketweight to Overweight.
However, Bernstein downgrades MRX from Outperform to Market Perform.
To see more analyst ratings on MRX Click Here.
Medicis Pharmaceutical Corporation operates as a specialty pharmaceutical company in the United States and Canada.
However, Bernstein downgrades MRX from Outperform to Market Perform.
To see more analyst ratings on MRX Click Here.
Medicis Pharmaceutical Corporation operates as a specialty pharmaceutical company in the United States and Canada.
You May Also Be Interested In
- UPDATE: UBS Downgrades Avon Products (AVP) to Sell; Still Cautious Even After Sell Off
- Wells Fargo Upgrades Enbridge Energy Partners (EEP) to Outperform; Weakness Provides Opportunity
- UBS Maintains a 'Neutral' on National Financial Partners (NFP); Expect Near-Term Headwinds to Persist
Create E-mail Alert Related Categories
Downgrades, UpgradesRelated Entities
Thomas Weisel Partners GroupSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
